WeightWatchers links Med+ GLP-1 program to Eli Lilly’s LillyDirect platform
Share
Listen to the news
WeightWatchers links Med+ GLP-1 program to Eli Lilly’s LillyDirect platform
  • WW International entered a collaboration with Eli Lilly’s LillyDirect to route patients to Weight Watchers’ Med+ weight-loss program.
  • LillyDirect users can connect to Med+, which combines GLP-1 access with licensed-provider care, behavioral support, nutrition guidance.
  • The tie-up targets rising demand for GLP-1 obesity drugs, aiming to expand access beyond prescriptions through an integrated care model.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. WW International Inc. published the original content used to generate this news brief on June 04, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending